# Omeros Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/omeros

- Industry: Pharmaceuticals
- Headquarters: Seattle, US
- Website: www.omeros.com
- Total disclosed funding: $63M
- Latest round: Series E (Feb 12, 2007)
- Investors on record: 8

## About

Omeros is based in US and operates as a commerical-based biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, coagulopathies and disorders of the central nervous system.

## Funding rounds

- Series E, Feb 12, 2007, $63M — ARCH Venture Partners, Aravis, Novartis Venture Fund, Grosvenor, Southern Cross Venture Partners, Trevi Health Ventures, WRF Capital, Stanley Medical Research Institute

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series E
- Aravis (https://capitalatlas.ai/funds/aravis) — Series E
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series E
- Grosvenor — Series E
- Southern Cross Venture Partners (https://capitalatlas.ai/funds/southern-cross-venture-partners) — Series E
- Trevi Health Ventures (https://capitalatlas.ai/funds/trevi-health-ventures) — Series E
- WRF Capital (https://capitalatlas.ai/funds/wrf-capital) — Series E
- Stanley Medical Research Institute — Series E